Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5186734
Max Phase: Preclinical
Molecular Formula: C45H59FN8O14S
Molecular Weight: 987.07
Associated Items:
ID: ALA5186734
Max Phase: Preclinical
Molecular Formula: C45H59FN8O14S
Molecular Weight: 987.07
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)c1ccc(S(=O)(=O)NC[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H]1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C1
Standard InChI: InChI=1S/C45H59FN8O14S/c1-21(2)14-32(44(63)50-23(4)42(61)51-26-12-13-53(19-26)34-16-33-29(15-31(34)46)38(57)30(45(64)65)20-54(33)27-8-9-27)52-36(55)18-47-41(60)22(3)49-43(62)25-6-10-28(11-7-25)69(66,67)48-17-35-39(58)40(59)37(56)24(5)68-35/h6-7,10-11,15-16,20-24,26-27,32,35,37,39-40,48,56,58-59H,8-9,12-14,17-19H2,1-5H3,(H,47,60)(H,49,62)(H,50,63)(H,51,61)(H,52,55)(H,64,65)/t22-,23-,24-,26-,32-,35+,37+,39+,40+/m0/s1
Standard InChI Key: MIUORFDZHLBJEF-DHNUKCHLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 987.07 | Molecular Weight (Monoisotopic): 986.3855 | AlogP: -1.01 | #Rotatable Bonds: 19 |
Polar Surface Area: 324.13 | Molecular Species: ACID | HBA: 15 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 5.87 | CX Basic pKa: | CX LogP: -1.35 | CX LogD: -2.89 |
Aromatic Rings: 3 | Heavy Atoms: 69 | QED Weighted: 0.07 | Np Likeness Score: -0.57 |
1. Meiers J, Rox K, Titz A.. (2022) Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release., 65 (20.0): [PMID:36201248] [10.1021/acs.jmedchem.2c01214] |
Source(1):